Publications — Radcliffe Department of Medicine

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Development of diagnostic algorithm for Cushing's syndrome: a tertiary centre experience.

Efthymiadis A. et al, (2024), J Endocrinol Invest

Service evaluation suggests variation in clinical care provision in adults with congenital adrenal hyperplasia in the UK and Ireland.

Doyle LM. et al, (2024), Clin Endocrinol (Oxf)

Recruitment, Retention, and Training of Citizen Scientists in Translational Medicine Research: A Citizen Science Initiative on Non-Alcoholic Fatty Liver Disease.

Shah SGS. et al, (2024), Cureus, 16

Progress is impossible without change: understanding the evolving nomenclature of steatotic liver disease and its effect on hepatology practice.

Brennan PN. et al, (2024), Lancet Gastroenterol Hepatol

Bardet‐Biedl syndrome: A focus on genetics, mechanisms and metabolic dysfunction

Tomlinson JW., (2024), Diabetes, Obesity and Metabolism

Alterations in plasma protein N-glycosylation after caloric restriction and bariatric surgery.

Štambuk T. et al, (2024), Surg Obes Relat Dis

Translating the potential of the urine steroid metabolome to stage NAFLD (TrUSt-NAFLD): study protocol for a multicentre, prospective validation study.

Miller H. et al, (2024), BMJ Open, 14

A novel model for predicting diabetes remission after bariatric surgery based on the measurement of C-peptide and creatinine in serum: A pilot study.

Colosimo S. et al, (2023), Nutr Metab Cardiovasc Dis

Profiling the genome and proteome of metabolic dysfunction-associated steatotic liver disease identifies potential therapeutic targets.

Liu J. et al, (2023), medRxiv

Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?

Pofi R. et al, (2023), Endocr Rev, 44, 975 - 1011

Multivariable Model to Predict an ACTH Stimulation Test to Diagnose Adrenal Insufficiency Using Previous Test Results.

Lawrence NR. et al, (2023), J Endocr Soc, 7

Identification of a human blood biomarker of pharmacological 11β-hydroxysteroid dehydrogenase 1 inhibition.

Gómez C. et al, (2023), Br J Pharmacol

Long-term health consequences of congenital adrenal hyperplasia.

Pofi R. et al, (2023), Clin Endocrinol (Oxf)

Assessing treatment adherence is crucial to determine adequacy of mineralocorticoid therapy.

Pofi R. et al, (2023), Endocr Connect, 12

Standardising the biochemical confirmation of adult male hypogonadism: A joint position statement by the Society for Endocrinology and Association of Clinical Biochemistry and Laboratory Medicine.

Jayasena CN. et al, (2023), Clin Endocrinol (Oxf)

Standardising the biochemical confirmation of adult male hypogonadism; a joint position statement by the Society for Endocrinology and Association of Clinical Biochemistry and Laboratory Medicine.

Jayasena CN. et al, (2023), Ann Clin Biochem

Tissue glucocorticoid metabolism in adrenal insufficiency: a prospective study of dual-release hydrocortisone therapy.

Dineen RA. et al, (2023), J Clin Endocrinol Metab

"A morning cortisol is the most effective clinical predictor of short synacthen test outcome": A tertiary care centre experience.

Mathara Diddhenipothage SAD. et al, (2023), Clin Endocrinol (Oxf)

Timing of energy intake and the therapeutic potential of intermittent fasting and time-restricted eating in NAFLD.

Marjot T. et al, (2023), Gut

Adopting a citizen science approach in translational experimental medicine research in non-alcoholic fatty liver disease: A study protocol

Shah SGS. et al, (2023)

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?